Oil
slumps. Middle Eastern patients cancel treatments abroad. Thai hospital stocks
slide.
It’s the
butterfly effect in action. Weak growth outlooks in the Gulf states are
prompting greater competition from local clinics, stemming the flow of visitors
to the world’s top medical tourism destination.
That’s
clouding the outlook for Thailand’s health-care shares, which surged more than
800 percent over the past seven years, as valuations start to look stretched
amid the falling demand. Bangkok’s Bumrungrad Hospital Plc, known as the
grandaddy of international clinics, has slumped 16 percent since early March
after patient volumes from the United Arab Emirates, its second-biggest source
of overseas visitors, fell 20 percent in the first quarter.
Thailand
attracted as many as 1.8 million international patients in 2015, many of whom
stayed on afterward for a beach holiday. More than one in three foreigners
treated at Bumrungrad are from the Gulf states and Kasikorn Securities Co. says
declining growth in the region and a rise in competition from clinics in the
U.A.E., where the government is encouraging its citizens to stay home for
medical care, are curbing demand.
“In the
short term, the economic slowdown in the the Middle East will weaken some
investors’ confidence on earnings growth for domestic hospital operators,” said
Jintana Mekintharanggur, the Bangkok-based director of equity investment at
Manulife Asset Management, which oversees about $325 billion globally. “We are
still bullish on the sector” in the long term as it will benefit from growth in
countries like Myanmar and Vietnam that have less-developed health systems, she
said.
The SET
Health Care Services Index has fallen 2.7 percent since closing at a record
high on April 21. It’s still the best-performing industry group in the SET
Index, rallying 27 percent over the past 12 months. It trades at 6.8 times its
book value, compared with 3.8 for the MSCI World Health Care Index.
The
health gauge closed down 0.2 percent on Monday as the SET Index rose 0.8
percent. Bangkok Dusit Medical Services Pcl, which has the biggest weighting on
the measure, dropped 1.2 percent and Bangkok Chain Hospital Pcl fell 1.8
percent.
“Most
hospital stocks have very stretched valuations, which has probably spurred some
concern about overestimated earnings potential,” said Adithep Vanabriksha,
Bangkok-based chief investment officer at Aberdeen Asset Management Plc. “We
still see their growth potential, but have to be very careful with the current
share prices.”
Between
1.3 million and 1.8 million medical tourists traveled to Thailand last year,
according to figures from Patients Beyond Borders, a consulting firm in Chapel
Hill, North Carolina. The country is well known for cosmetic and sex change
procedures. Medical tourism generated 107 billion baht ($3 billion) of revenue
in 2014, according to the latest Thai government estimate.
Sitting
at the apex of the industry is Bumrungrad, which attracts more than half a million
foreign patients a year and has a network of 32 referral offices everywhere
from Mongolia to Ethiopia. Sixty-seven percent of revenue came from overseas
visitors last quarter, company figures show. Myanmar residents were the biggest
source, accounting for 8.4 percent of total patients, followed by 8.3 percent
from the U.A.E. and 5.9 percent from Oman.
Kasikorn
Securities downgraded its earning forecasts for Bumrungrad by 8 percent to 13
percent in 2016 to 2018 to reflect the weak economic outlook in the Gulf and
rising competition from Abu Dhabi’s Al Noor Hospitals Group, according to a May
19 note by analyst Jitima Ratanatam in Bangkok. The U.A.E.’s economy has been
hit by the plunge in oil since mid-2014 and is forecast to expand 2.5 percent
this year, from more than 7 percent in 2012.
Other
Thai hospitals are also under pressure. Chiang Mai Ram Medical Business Pcl
reported a 41 percent slump in first-quarter profit. Bangkok Dusit was
downgraded to neutral from outperform by Credit Suisse Group AG last week.
Recognizing
the importance of health care to the Thai economy, Prime Minister Prayuth
Chan-Ocha’s military government has drafted a 10-year plan to promote the
sector. As part of the plan, the staying period for medical treatment for
patients from China, Laos, Cambodia, Myanmar and Vietnam has been tripled to 90
days.
Southeast Asian Demand
Even if
Middle East demand keeps declining, growth in Southeast Asia will support the
industry, said Voravan Tarapoom, the Bangkok-based chief executive officer at
BBL Asset Management Co., which oversees $15 billion.
Manulife
has cut holdings in Bangkok Dusit because its rising share price provided an
opportunity to lock in profit, said Jintana. It’s buying Bumrungrad because
it’s dropped to an attractive level and the asset manager is also looking at
other health companies but is wary of high valuations, she said.
“Health-care
stocks were the good defensive stocks during the market downturn,” said Kasem
Prunratanamala, the head of research at CIMB Securities (Thailand) Co. in
Bangkok. “Now, with the high valuations, those shares have lost a little bit of
allure.”
Anuchit
Nguyen
No comments:
Post a Comment